Fig. 2From: Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational studyAdjusted HR at Cox Proportional Hazard Model for Dual-Therapy Discontinuation: Second DrugBack to article page